Immuneering (IMRX) Q3 2025 Earnings

13AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.58
-0.52
-0.46
-0.4

Details

Expected EPS
-0.400267
Actual EPS
-0.4
Surprise EPS
0
Surprise Percent
+0.07%

Description

Immuneering (IMRX) has reported earnings of -0.4 per share for Q3 2025.

0 Comments

Share your thoughts